LSL Pharma Group Inc. (LSL.V)
| Previous close | 0.4200 |
| Open | 0.3900 |
| Bid | 0.4200 x N/A |
| Ask | 0.4300 x N/A |
| Day's range | 0.3900 - 0.4200 |
| 52-week range | 0.3500 - 0.5700 |
| Volume | |
| Avg. volume | 39,158 |
| Market cap | 45.362M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0500 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireLSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights
FY-2023 Revenues increased by 22% at $10.0 million compared to $8.2 million for FY-2022, a $1.8 million increase.Gross margins for FY-2023 up $3.8 million compared to FY-2022Net loss for FY-2023 of $8.5 million compared to $8.1 million for FY-2022Q4-2023 Revenues of $3.5 million, up 51% over Q4-2022 revenues of $2.3 millionQ4-2023 EBITDA profit of $0.3 million compared to an EBITDA loss of $2.2 million for Q4-2022Q4-2023 Net loss of $0.5 million compared to a net loss of $3 million for Q4-2022In
- GlobeNewswire
LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units
BOUCHERVILLE, Quebec, April 24, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the second and final tranche of its private placement financing of Units (as defined hereafter) for $3.8 million representing the second closing of the upsized $7.5 million non-brokered private placement announced on April 11, 2024 (the “Financing”). The second tranche follows an initial first closing of $2.7
- GlobeNewswire
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
BOUCHERVILLE, Quebec, April 23, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the appointment of Diane Beaudry and Mario Paradis to its Board of Directors. "It is my pleasure and privilege to announce the addition of two new members to the LSL Pharma Group Board of Directors, including our first female representative," said Mr. François Roberge, Chairman of the Board. "Diane Beaudry and Ma
